|
1
|
Glerup M, Herlin T and Twilt M: Clinical
outcome and long-term remission in JIA. Curr Rheumatol Rep.
19:752017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Selvaag AM, Aulie HA, Lilleby V and Flato
B: Disease progression into adulthood and predictors of long-term
active disease in juvenile idiopathic arthritis. Ann Rheum Dis.
75:190–195. 2016. View Article : Google Scholar
|
|
3
|
Ruperto N and Martini A: Current and
future perspectives in the management of juvenile idiopathic
arthritis. Lancet Child Adolesc Health. 2:360–370. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berntson L, Fasth A, Andersson-Gäre B,
Kristinsson J, Lahdenne P, Marhaug G, Nielsen S and Pelkonen P;
Svensson E; Nordic Study Group: Construct validity of ILAR and
EULAR criteria in juvenile idiopathic arthritis: A population based
incidence study from the Nordic countries. International league of
associations for rheumatology. European league against rheumatism J
Rheumatol. 28:2737–2743. 2001.
|
|
5
|
Horneff G, Klein A, Ganser G, Sailer-Höck
M, Günther A, Foeldvari I and Weller-Heinemann F: Protocols on
classification, monitoring and therapy in children's rheumatology
(PRO-KIND): Results of the working group polyarticular juvenile
idiopathic arthritis. Pediatr Rheumatol Online J. 15:782017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hinks A, Marion MC, Cobb J, Comeau ME,
Sudman M, Ainsworth HC, Bowes J; Juvenile Idiopathic Arthritis
Consortium for Immunochip; Becker ML, Bohnsack JF, et al: Brief
report: The genetic profile of rheumatoid factor-positive
polyarticular juvenile idiopathic arthritis resembles that of adult
rheumatoid arthritis. Arthritis Rheumatol. 70:957–962. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Komatsu N, Okamoto K, Sawa S, Nakashima T,
Oh-hora M, Kodama T, Tanaka S, Bluestone JA and Takayanagi H:
Pathogenic conversion of Foxp3+ T cells into TH17 cells
in autoimmune arthritis. Nat Med. 20:62–68. 2014. View Article : Google Scholar
|
|
8
|
Niu Q, Cai B, Huang ZC, Shi YY and Wang
LL: Disturbed Th17/Treg balance in patients with rheumatoid
arthritis. Rheumatol Int. 32:2731–2736. 2012. View Article : Google Scholar
|
|
9
|
Alunno A, Manetti M, Caterbi S,
Ibba-Manneschi L, Bistoni O, Bartoloni E, Valentini V, Terenzi R
and Gerli R: Altered immunoregulation in rheumatoid arthritis: The
role of regulatory T cells and proinflammatory Th17 cells and
therapeutic implications. Mediators Inflamm. 2015:7517932015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boissier MC, Assier E, Falgarone G and
Bessis N: Shifting the imbalance from Th1/Th2 to Th17/treg: The
changing rheumatoid arthritis paradigm. Joint Bone Spine.
75:373–375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stelmaszczyk-Emmel A, Jackowska T,
Rutkowska-Sak L, Marusak-Banacka M and Wasik M: Identification,
frequency, activation and function of CD4+ CD25(high)FoxP3+
regulatory T cells in children with juvenile idiopathic arthritis.
Rheumatol Int. 32:1147–1154. 2012. View Article : Google Scholar
|
|
12
|
Szymańska-Kałuża J, Cebula-Obrzut B,
Smolewski P, Stanczyk J and Smolewska E: Imbalance of Th17 and
T-regulatory cells in peripheral blood and synovial fluid in
treatment naïve children with juvenile idiopathic arthritis. Cent
Eur J Immunol. 39:71–76. 2014. View Article : Google Scholar
|
|
13
|
Nistala K, Moncrieffe H, Newton KR,
Varsani H, Hunter P and Wedderburn LR: Interleukin-17-producing T
cells are enriched in the joints of children with arthritis, but
have a reciprocal relationship to regulatory T cell numbers.
Arthritis Rheum. 58:875–887. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu SA, Yeh KW, Lee WI, Yao TC and Huang
JL: Persistent improper upregulation of Th17 and TReg cells in
patients with juvenile idiopathic arthritis. J Microbiol Immunol
Infect. 49:402–408. 2016. View Article : Google Scholar
|
|
15
|
Bending D, Pesenacker AM, Ursu S, Wu Q,
Lom H, Thirugnanabalan B and Wedderburn LR: Hypomethylation at the
regulatory T cell-specific demethylated region in CD25hi T cells is
decoupled from FOXP3 expression at the inflamed site in childhood
arthritis. J Immunol. 193:2699–2708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YG, Satpathy AT and Chang HY: Gene
regulation in the immune system by long noncoding RNAs. Nat
Immunol. 18:962–972. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Yang X, Sun X, Rong L, Kang M, Wu
P, Ji X, Lin R, Huang J, Xue Y and Fang Y: Bone marrow infiltrated
Lnc-INSR induced suppressive immune microenvironment in pediatric
acute lymphoblastic leukemia. Cell Death Dis. 9:10432018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu G, Tang Q, Sharma S, Yu F, Escobar TM,
Muljo SA, Zhu J and Zhao K: Expression and regulation of intergenic
long noncoding RNAs during T cell development and differentiation.
Nat Immunol. 14:1190–1198. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Collier SP, Henderson MA, Tossberg JT and
Aune TM: Regulation of the Th1 genomic locus from Ifng through
Tmevpg1 by T-bet. J Immunol. 193:3959–3965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ranzani V, Rossetti G, Panzeri I, Arrigoni
A, Bonnal RJ, Curti S, Gruarin P, Provasi E, Sugliano E, Marconi M,
et al: The long intergenic noncoding RNA landscape of human
lymphocytes highlights the regulation of T cell differentiation by
linc-MAF-4. Nat Immunol. 16:318–325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie
Y, Wang K, Jia W, Chu WM and Sun B: The long noncoding RNA lnc-EGFR
stimulates T-regulatory cells differentiation thus promoting
hepatocellular carcinoma immune evasion. Nat Commun. 8:151292017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan SX, Wang J, Yang F, Tao QF, Zhang J,
Wang LL, Yang Y, Liu H, Wang ZG, Xu QG, et al: Long noncoding RNA
DANCR increases stemness features of hepatocellular carcinoma by
derepression of CTNNB1. Hepatology. 63:499–511. 2016. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Jia H, Osak M, Bogu GK, Stanton LW,
Johnson R and Lipovich L: Genome-wide computational identification
and manual annotation of human long noncoding RNA genes. RNA.
16:1478–1487. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hinze C, Gohar F and Foell D: Management
of juvenile idiopathic arthritis: Hitting the target. Nat Rev
Rheumatol. 11:290–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Roy S and Awasthi A: Emerging roles of
noncoding RNAs in T cell differentiation and functions in
autoimmune diseases. Int Rev Immunol. 38:232–245. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Collier SP, Collins PL, Williams CL,
Boothby MR and Aune TM: Cutting edge: Influence of Tmevpg1, a long
intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J
Immunol. 189:2084–2088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pesenacker AM and Wedderburn LR: T
regulatory cells in childhood arthritis-novel insights. Expert Rev
Mol Med. 15:e132013. View Article : Google Scholar
|
|
32
|
Lawson CA, Brown AK, Bejarano V, Douglas
SH, Burgoyne CH, Greenstein AS, Boylston AW, Emery P, Ponchel F and
Isaacs JD: Early rheumatoid arthritis is associated with a deficit
in the CD4+CD25high regulatory T cell population in peripheral
blood. Rheumatology (Oxford). 45:1210–1217. 2006. View Article : Google Scholar
|
|
33
|
Shui X, Chen S, Lin J, Kong J, Zhou C and
Wu J: Knockdown of lncRNA NEAT1 inhibits Th17/CD4+ T
cell differentiation through reducing the STAT3 protein level. J
Cell Physiol. 234:22477–22484. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Burnstock G: Pathophysiology and
therapeutic potential of purinergic signaling. Pharmacol Rev.
58:58–86. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schenk U, Frascoli M, Proietti M, Geffers
R, Traggiai E, Buer J, Ricordi C, Westendorf AM and Grassi F: ATP
inhibits the generation and function of regulatory T cells through
the activation of purinergic P2X receptors. Sci Signal. 4:ra122011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fan ZD, Zhang YY, Guo YH, Huang N, Ma HH,
Huang H and Yu HG: Involvement of P2X7 receptor signaling on
regulating the differentiation of Th17 cells and type II
collagen-induced arthritis in mice. Sci Rep. 6:358042016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen HH, Yang YX, Meng X, Luo XY, Li XM,
Shuai ZW, Ye DQ and Pan HF: NLRP3: A promising therapeutic target
for autoimmune diseases. Autoimmun Rev. 17:694–702. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choulaki C, Papadaki G, Repa A, Kampouraki
E, Kambas K, Ritis K, Bertsias G, Boumpas DT and Sidiropoulos P:
Enhanced activity of NLRP3 inflammasome in peripheral blood cells
of patients with active rheumatoid arthritis. Arthritis Res Ther.
17:2572015. View Article : Google Scholar : PubMed/NCBI
|
